Dato' Dr Mohd Nazlee Kamal, CEO of Malaysian BiotechCorp, commented, "Malaysia's strategy to become a biotech hub for Asia is rapidly gaining traction, and this Viropro-Oncobiologics partnership is a significant step in moving this effort forward. BiotechCorp is proud to be part of this collaboration and we look forward to many great developments. This project will attract interest in the biosimilars manufacturing field and will certainly build the confidence of global biotech companies in Malaysian companies as we strive to develop the biomedical sector in the country."

Malaysian BiotechCorp is an agency under the Ministry of Science, Technology and Innovation responsible for executing the objectives of the National Biotechnology Policy.